Viewing Study NCT05112861

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:15 PM
Ignite Modification Date: 2026-02-09 @ 1:14 AM
Study NCT ID: NCT05112861
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-02
First Post: 2021-10-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders
Sponsor: Outlook Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Age-Related Macular Degeneration View
None Neovascular Age-related Macular Degeneration View
None Wet Macular Degeneration View
None BRVO - Branch Retinal Vein Occlusion View
None Diabetic Macular Edema View
Keywords: